Download PDF
Thorac Cardiovasc Surg
DOI: 10.1055/s-0044-1791233
Review Article

Clinical Outcomes with High- versus Low-Dose Tranexamic Acid Infusion in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis

Hussain Sohail Rangwala
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Burhanuddin Sohail Rangwala
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Moath Alotaibi
2   Department of Medicine, Imam Abdulrahman Bin Faisal University College of Medicine, Dammam, Eastern, Saudi Arabia
,
Mohammad Arham Siddiq
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Amna Qamber
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Syeda Dua E. Zehra Zaidi
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Tooba Naveed
3   Department of Medicine, Ziauddin Medical College, Karachi, Sindh, Pakistan
,
Hufsa Naveed
3   Department of Medicine, Ziauddin Medical College, Karachi, Sindh, Pakistan
,
Syed Talal Azam
1   Department of Medicine, Jinnah Sindh Medical University, Karachi, Sindh, Pakistan
,
Ishaque Hameed
4   Department of Medicine, MedStar Health, Baltimore, Maryland, United States
› Author Affiliations
› Further Information
    Permissions and Reprints All articles of this category

Abstract

Objectives Antifibrinolytics, such as tranexamic acid (TXA), are widely used in cardiac surgery to reduce bleeding risks; however, the optimal dosage for TXA infusion remains a subject of debate. Hence, this study aims to evaluate the safety and efficacy of high-dose compared with low-dose TXA infusion in cardiac surgery patients.

Methods PubMed, SCOPUS, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched until June 10, 2023, for studies assessing efficacy outcomes (e.g., blood loss, transfusions) and safety outcomes (e.g., mortality, complications).

Results Results were analyzed via random-effects model, using Mantel-Haenszel risk ratio (RR) and standard mean difference (SMD). P-value < 0.05 was considered significant. We analyzed 17 studies involving 93,206 participants (mean age 59.3 years, study duration 3 months to 10 years). Our analysis found significant reductions in total blood loss (SMD, −0.17 g; CI, −0.34 to −0.01; p = 0.04), 24-hour blood loss (SMD, −0.23 g; p = 0.005), and the need for fresh frozen plasma (FFP) transfusions (RR: 0.94; CI, 0.89 to 1.00; p = 0.05) with high-dose TXA. Chest tube output was also lower (SMD, −0.12 g; p = 0.0006), but postoperative seizures increased (RR: 2.23; CI, 1.70 to 2.93; p < 0.00001) with high-dose TXA. For other outcomes like blood transfusions, hospital/ICU stay, mortality, stroke, myocardial infarction, pulmonary embolism, renal dysfunction, and reoperation, no significant differences were found between high-dose and low-dose TXA regimens.

Conclusion Our study showed that high TXA dose effectively reduce postoperative bleeding, chest tube drainage, and the need for FFP transfusion, but it increases the risk of seizures. Increasing TXA dose did not affect thromboembolic events or mortality. This emphasizes the importance of weighing the benefits and risks when selecting the appropriate TXA regimen for each patient.

Keywords

tranexamic acid - antifibrinolytics - cardiac surgery - blood loss - optimal dosage

Authors' Contribution

H.S.R. contributed to Conceptualization, Investigation, Formal Analysis, Writing - Original Draft; B.S.R. contributed to Investigation, Formal Analysis, Writing - Original Draft; M.A. contributed to Writing - Review & Editing, Supervision; M.A.S. contributed to Investigation, Formal Analysis, Writing - Review & Editing; A.Q. contributed to Validation, Writing - Original Draft; S.D.Z.Z. contributed to Validation, Writing - Original Draft; T.N. contributed to Validation, Methodology, Writing - Original Draft; H.N. contributed to Validation, Methodology, Writing - Original Draft; S.T.A. contributed to Validation, Writing - Original Draft; and I.H. contributed to Conceptualization, Writing - Review & Editing, Supervision.


Supplementary Material



Publication History

Received: 18 May 2024

Accepted: 29 August 2024

Article published online:
22 January 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Fergusson DA, Hébert PC, Mazer CD. et al; BART Investigators. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med 2008; 358 (22) 2319-2331
    CrossrefPubMedSearch in Google Scholar
  • 2 Chauhan S, Das SN, Bisoi A, Kale S, Kiran U. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18 (02) 141-143
    CrossrefPubMedSearch in Google Scholar
  • 3 Taam J, Yang QJ, Pang KS. et al. Current evidence and future directions of tranexamic acid use, efficacy, and dosing for major surgical procedures. J Cardiothorac Vasc Anesth 2020; 34 (03) 782-790
    CrossrefPubMedSearch in Google Scholar
  • 4 Henry DA, Carless PA, Moxey AJ. et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2011; (01) CD001886
    PubMedSearch in Google Scholar
  • 5 Martin J, Cheng D. Tranexamic acid for routine use in off-pump coronary artery bypass surgery: evidence base “fait accompli” or more research needed?. Anesth Analg 2012; 115 (02) 227-230
    CrossrefPubMedSearch in Google Scholar
  • 6 Lum ZC, Manoukian MAC, Pacheco CS, Nedopil AJ, Giordani M, Meehan JP. Intravenous tranexamic acid versus topical aminocaproic acid: Which method has the least blood loss and transfusion rates?. J Am Acad Orthop Surg Glob Res Rev 2018; 2 (11) e072
    PubMedSearch in Google Scholar
  • 7 Ahn SW, Shim JK, Youn YN. et al. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circ J 2012; 76 (01) 96-101
    CrossrefPubMedSearch in Google Scholar
  • 8 Dai Z, Chu H, Wang S, Liang Y. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: a systematic review and cumulative meta-analysis. J Clin Anesth 2018; 44: 23-31
    CrossrefPubMedSearch in Google Scholar
  • 9 Khadanga P, Kanchi M, Gaur P. Effectiveness of tranexamic acid in reducing postoperative blood loss in patients undergoing off-pump coronary artery bypass grafting. Cureus 2020; 12 (12) e11924
    PubMedSearch in Google Scholar
  • 10 Sigaut S, Tremey B, Ouattara A. et al. Comparison of two doses of tranexamic acid in adults undergoing cardiac surgery with cardiopulmonary bypass. Anesthesiology 2014; 120 (03) 590-600
    CrossrefPubMedSearch in Google Scholar
  • 11 Waldow T, Szłapka M, Haferkorn M, Bürger L, Plötze K, Matschke K. Prospective clinical trial on dosage optimizing of tranexamic acid in non-emergency cardiac surgery procedures. Clin Hemorheol Microcirc 2013; 55 (04) 457-468
    CrossrefPubMedSearch in Google Scholar
  • 12 Lambert W, Brisebois FJ, Wharton TJ, Carrier RC, Boyle D, Rowe BH. The effectiveness of low dose tranexamic acid in primary cardiac surgery. Can J Anaesth 1998; 45 (06) 571-574
    CrossrefPubMedSearch in Google Scholar
  • 13 Jiménez JJ, Iribarren JL, Brouard M. et al. Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial. J Cardiothorac Surg 2011; 6 (01) 138
    CrossrefPubMedSearch in Google Scholar
  • 14 Karski JM, Dowd NP, Joiner R. et al. The effect of three different doses of tranexamic acid on blood loss after cardiac surgery with mild systemic hypothermia (32 ° C). J Cardiothorac Vasc Anesth 1998; 12 (06) 642-646
    CrossrefPubMedSearch in Google Scholar
  • 15 Brown JR, Birkmeyer NJO, O'Connor GT. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 115 (22) 2801-2813
    CrossrefPubMedSearch in Google Scholar
  • 16 Dowd NP, Karski JM, Cheng DC. et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97 (02) 390-399
    CrossrefPubMedSearch in Google Scholar
  • 17 Horrow JC, Van Riper DF, Strong MD, Grunewald KE, Parmet JL. The dose-response relationship of tranexamic acid. Anesthesiology 1995; 82 (02) 383-392
    CrossrefPubMedSearch in Google Scholar
  • 18 Myles PS, Smith JA, Forbes A. et al; ATACAS Investigators of the ANZCA Clinical Trials Network. Tranexamic acid in patients undergoing coronary-artery surgery. N Engl J Med 2017; 376 (02) 136-148
    CrossrefPubMedSearch in Google Scholar
  • 19 Rao G, López-Jiménez F, Boyd J. et al; American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; and Stroke Council. Methodological standards for meta-analyses and qualitative systematic reviews of cardiac prevention and treatment studies: a scientific statement from the American Heart Association. Circulation 2017; 136 (10) e172-e194
    PubMedSearch in Google Scholar
  • 20 Liberati A, Altman DG, Tetzlaff J. et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62 (10) e1-e34
    CrossrefPubMedSearch in Google Scholar
  • 21 Wells G, Shea BO'Connell D. et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Sci Educ 2014
    PubMedSearch in Google Scholar
  • 22 Higgins JPT, Thomas J, Chandler J. et al, eds. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023. Accessed at: www.training.cochrane.org/handbook
    PubMed
  • 23 Du Y, Xu J, Wang G. et al. Comparison of two tranexamic acid dose regimens in patients undergoing cardiac valve surgery. J Cardiothorac Vasc Anesth 2014; 28 (05) 1233-1237
    CrossrefPubMedSearch in Google Scholar
  • 24 Shi J, Zhou C, Pan W. et al; OPTIMAL Study Group. Effect of high- vs low-dose tranexamic acid infusion on need for red blood cell transfusion and adverse events in patients undergoing cardiac surgery: the OPTIMAL randomized clinical trial. JAMA 2022; 328 (04) 336-347
    CrossrefPubMedSearch in Google Scholar
  • 25 Wang E, Yuan X, Wang Y. et al. Tranexamic acid administered during off-pump coronary artery bypass graft surgeries achieves good safety effects and hemostasis. Front Cardiovasc Med 2022; 9: 775760
    CrossrefPubMedSearch in Google Scholar
  • 26 Wang E, Yuan X, Wang Y. et al. Blood conservation outcomes and safety of tranexamic acid in coronary artery bypass graft surgery. Int J Cardiol 2022; 348: 50-56
    CrossrefPubMedSearch in Google Scholar
  • 27 Borrás J, Moncho AP, Puig J. et al. Ácido tranexámico en cirugía cardíaca: ¿las dosis bajas son suficientes? [Tranexamic acid in cardiac surgery: are low doses enough?]. Rev Esp Anestesiol Reanim 2021; 68 (10) 576-583
    CrossrefPubMedSearch in Google Scholar
  • 28 Hulde N, Zittermann A, Deutsch MA, von Dossow V, Gummert JE, Koster A. Moderate dose of tranexamic acid and complications after valvular heart surgery. Thorac Cardiovasc Surg 2023; 71 (03) 181-188
    Thieme ConnectPubMedSearch in Google Scholar
  • 29 Couture P, Lebon JS, Laliberté É. et al. Low-dose versus high-dose tranexamic acid reduces the risk of nonischemic seizures after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2017; 31 (05) 1611-1617
    CrossrefPubMedSearch in Google Scholar
  • 30 McHugh SM, Kolarczyk L, Lang RS, Wei LM, Jose M, Subramaniam K. A comparison of high-dose and low-dose tranexamic acid antifibrinolytic protocols for primary coronary artery bypass surgery. Indian J Anaesth 2016; 60 (02) 94-101
    CrossrefPubMedSearch in Google Scholar
  • 31 Faraoni D, Cacheux C, Van Aelbrouck C, Ickx BE, Barvais L, Levy JH. Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study. Eur J Anaesthesiol 2014; 31 (09) 491-498
    CrossrefPubMedSearch in Google Scholar
  • 32 Peña JJ, Mateo E, Martín E, Llagunes J, Carmona P, Blasco L. en representación del Grupo de trabajo de Anestesiología y Cuidados Críticos de Cirugía Cardiaca en la Comunidad Valenciana. Hemorragia y morbilidad asociada al uso de ácido tranexámico en cirugía cardiaca. Estudio multicéntrico de cohortes retrospectivo [Haemorrhage and morbidity associated with the use of tranexamic acid in cardiac surgery: a retrospective, multicentre cohort study]. Rev Esp Anestesiol Reanim 2013; 60 (03) 142-148
    CrossrefPubMedSearch in Google Scholar
  • 33 Armellin G, Vinciguerra A, Bonato R, Pittarello D, Giron GP. Tranexamic acid in primary CABG surgery: high vs low dose. Minerva Anestesiol 2004; 70 (03) 97-107
    PubMedSearch in Google Scholar
  • 34 Casati V, Bellotti F, Gerli C. et al. Tranexamic acid administration after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled study. Anesthesiology 2001; 94 (01) 8-14
    CrossrefPubMedSearch in Google Scholar
  • 35 Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y. Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations. J Thorac Cardiovasc Surg 1997; 113 (04) 802-804
    CrossrefPubMedSearch in Google Scholar
  • 36 Karski JM, Teasdale SJ, Norman P. et al. Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial. J Thorac Cardiovasc Surg 1995; 110 (03) 835-842
    CrossrefPubMedSearch in Google Scholar
  • 37 Sharma V, Fan J, Jerath A. et al. Pharmacokinetics of tranexamic acid in patients undergoing cardiac surgery with use of cardiopulmonary bypass. Anaesthesia 2012; 67 (11) 1242-1250
    CrossrefPubMedSearch in Google Scholar
  • 38 Dowd NP, Karski JM, Cheng DC. et al. Pharmacokinetics of tranexamic acid during cardiopulmonary bypass. Anesthesiology 2002; 97 (02) 390-399
    CrossrefPubMedSearch in Google Scholar
  • 39 Guo J, Gao X, Ma Y. et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol 2019; 19 (01) 129
    CrossrefPubMedSearch in Google Scholar
  • 40 Takagi H, Ando T, Umemoto T. All-Literature Investigation of Cardiovascular Evidence (ALICE) group. Seizures associated with tranexamic acid for cardiac surgery: a meta-analysis of randomized and non-randomized studies. J Cardiovasc Surg (Torino) 2017; 58 (04) 633-641
    PubMedSearch in Google Scholar
  • 41 Lin Z, Xiaoyi Z. Tranexamic acid-associated seizures: a meta-analysis. Seizure 2016; 36: 70-73
    CrossrefPubMedSearch in Google Scholar
  • 42 Furtmüller R, Schlag MG, Berger M. et al. Tranexamic acid, a widely used antifibrinolytic agent, causes convulsions by a γ-aminobutyric acid(A) receptor antagonistic effect. J Pharmacol Exp Ther 2002; 301 (01) 168-173
    CrossrefPubMedSearch in Google Scholar
  • 43 Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA. Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012; 122 (12) 4654-4666
    CrossrefPubMedSearch in Google Scholar
  • 44 Lecker I, Wang DS, Whissell PD, Avramescu S, Mazer CD, Orser BA. Tranexamic acid-associated seizures: causes and treatment. Ann Neurol 2016; 79 (01) 18-26
    CrossrefPubMedSearch in Google Scholar
  • 45 Spinella PC, Bochicchio K, Thomas KA. et al. The risk of thromboembolic events with early intravenous 2- and 4-g bolus dosing of tranexamic acid compared to placebo in patients with severe traumatic bleeding: a secondary analysis of a randomized, double-blind, placebo-controlled, single-center trial. Transfusion 2022; 62 (Suppl. 01) S139-S150
    PubMedSearch in Google Scholar
  • 46 Murao S, Nakata H, Roberts I, Yamakawa K. Effect of tranexamic acid on thrombotic events and seizures in bleeding patients: a systematic review and meta-analysis. Crit Care 2021; 25 (01) 380
    CrossrefPubMedSearch in Google Scholar
  • 47 Dai Z, Chu H, Wang S, Liang Y. The effect of tranexamic acid to reduce blood loss and transfusion on off-pump coronary artery bypass surgery: a systematic review and cumulative meta-analysis. J Clin Anesth 2018; 44: 23-31
    CrossrefPubMedSearch in Google Scholar
  • 48 Colomina MJ, Contreras L, Guilabert P, Koo M, M Ndez E, Sabaté A. Clinical use of tranexamic acid: evidences and controversies. Braz J Anesthesiol 2022; 72 (06) 795-812
    PubMedSearch in Google Scholar